ArticleFrontiers in immunology2017
AIMp1 Potentiates T
Open access · goldAbstract read
In one paragraph
Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 35 citations in OpenAlex.
- Dissolving Silver Nanoparticles Modulate the Endothelial Monocyte-Activating Polypeptide II (EMAP II) by Partially Unfolding the Protein Leading to tRNA Binding Enhancement.International journal of molecular sciences · 2026Article
- Aminoacyl-tRNA synthetases in tumor immunity: canonical translation, source-resolved immune circuits and therapeutic opportunities.Frontiers in immunology · 2026Review
- Case Report: Primed dendritic cell immunotherapy for multiple solid tumors.Frontiers in immunology · 2026Article
- Integrated Genomic-Metabolomic Analysis for Tri-Categorical Classification of Type 2 Diabetes Status in the Korean Ansan-Ansung Cohort.International journal of molecular sciences · 2025Article
- AIMP1: multifunctional regulator in physiology and pathology with therapeutic implications.PeerJ · 2025Review
- Anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 antibody improves airway inflammation in mice with house dust mite induced asthma.The World Allergy Organization journal · 2024Article
- The mARS complex: a critical mediator of immune regulation and homeostasis.Frontiers in immunology · 2024Review
- Immune inhibitory receptor-mediated immune response, metabolic adaptation, and clinical characterization in patients with COVID-19.Scientific reports · 2023Article
- Immunomodulatory proteins from hookworms reduce cardiac inflammation and modulate regulatory responses in a mouse model of chronicFrontiers in parasitology · 2023Article
- Comparative transcriptomic analysis of PK15 cells infected with a PRV variant and the Bartha-K/61 vaccine strain.Frontiers in microbiology · 2023Article
- Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.BMC genomic data · 2022Article
- Review
- Investigating the effects of Liushen Capsules on the metabolome of seasonal influenza: A randomized clinical trial.Frontiers in pharmacology · 2022Article
- 3D Collagen Fiber Concentration Regulates Treg Cell Infiltration in Triple Negative Breast Cancer.Frontiers in immunology · 2022Article
- Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma.Cancer biomarkers : section A of Disease markers · 2022Article
- Article
- A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma.Science translational medicine · 2021Article
- The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.Frontiers in physiology · 2021Article
- Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer.Cell death & disease · 2020Review
- MHC class I and II peptide homology regulates the cellular immune response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 3 institutions in 2 countries.
Dan LiangDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Lin TianDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
Ran YouDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Matthew M HalpertDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Vanaja KonduriDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Yunyu C BaigDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Silke PaustDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Doyeun KimMedicinal Bioconvergence Research Center, Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, South Korea.
Sunghoon KimMedicinal Bioconvergence Research Center, Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, South Korea.
Fuli JiaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
Shixia HuangDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
Xiang ZhangDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
Farrah KheradmandDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
David B CorryDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Brian E GilbertDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
Jonathan M LevittDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
William K DeckerDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
Baylor College of Medicine · USChildren's Cancer Center · USSeoul National University · KR
Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8MTumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9MVirology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7MRegulation of Innate Dendritic Cell CTLA-4R01AI127387 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI WILLIAM Karl DECKER · 2017 to 2026
$3.9MBD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430kNCI NIH HHS P30 CA016672NCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211NIAID NIH HHS R01 AI127387
Abstract
Dendritic cells (DCs) must integrate a broad array of environmental cues to exact control over downstream immune responses including T
Indexed as
AIMp1antitumor immunityantiviral immunitydendritic cellIL-12p38 MAPK signalingTH1 immunity
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.